Posted:
Researchers at Oregon Health & Science University and Anhui University in China published a study in the Proceedings of the National Academy of Sciences identifying a specific brain circuit that connects serotonin signaling to the auditory system. Using optogenetics in a mouse model, the researchers found that activating serotonin-producing neurons triggered behavioral symptoms consistent with tinnitus. When that circuit was turned off, tinnitus-like signs decreased.
The findings offer a possible explanation for why some people report worsening tinnitus while taking SSRIs, a class of antidepressants that increases serotonin levels in the brain. The researchers noted a clinical dichotomy: SSRIs are among the most common treatments for depression and anxiety, conditions that frequently co-occur with tinnitus, but the same mechanism that relieves mood symptoms may aggravate auditory ones. The research team suggested future drug development might focus on modulating serotonin in region-specific ways to preserve antidepressant benefits while reducing auditory side effects.
Several important limitations apply. This was an animal study. The circuit identified in mice may not map directly onto human auditory or serotonergic systems, and the clinical significance of the finding for people taking SSRIs is not yet established.
Learn more here.
